Retraction: Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Withdrawal: Comprehensive multi-omics study identifies complement component 3 as a key factor in immune imbalance associated with polycystic ovary syndrome

  • June 5, 2026

Share

Original Source(s)

Retraction: Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome

  • June 5, 2026

Related Content

PCOS Renamed PMOS After Global Consensus

International initiative reframes a common endocrine disorder around its metabolic and ovarian features rather than ovarian cysts

Pulsatile GnRH Pump Therapy Leads to Ovulation and Pregnancy in a Patient with Polycystic Ovary Syndrome: A Case Study

Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis